These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 9489587)

  • 1. Suppression of tumour development by substances derived from the diet--mechanisms and clinical implications.
    Gescher A; Pastorino U; Plummer SM; Manson MM
    Br J Clin Pharmacol; 1998 Jan; 45(1):1-12. PubMed ID: 9489587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin chemoprevention: the long road to clinical translation.
    Shureiqi I; Baron JA
    Cancer Prev Res (Phila); 2011 Mar; 4(3):296-8. PubMed ID: 21372027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New agents for cancer chemoprevention.
    Kelloff GJ; Boone CW; Crowell JA; Steele VE; Lubet RA; Doody LA; Malone WF; Hawk ET; Sigman CC
    J Cell Biochem Suppl; 1996; 26():1-28. PubMed ID: 9154166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic considerations in the evaluation of chemopreventive data.
    Kelloff GJ; Boone CW; Steele VE; Crowell JA; Lubet RA; Greenwald P; Hawk ET; Fay JR; Sigman CC
    IARC Sci Publ; 1996; (139):203-19. PubMed ID: 8923032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of chemoprevention in cancer control.
    Greenwald P; Kelloff GJ
    IARC Sci Publ; 1996; (139):13-22. PubMed ID: 8923016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic considerations in chemopreventive drug development.
    Kelloff GJ; Boone CW; Steele VE; Fay JR; Lubet RA; Crowell JA; Sigman CC
    J Cell Biochem Suppl; 1994; 20():1-24. PubMed ID: 7616736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in prostate cancer chemoprevention: a translational perspective.
    Nambiar D; Singh RP
    Nutr Cancer; 2013; 65 Suppl 1():12-25. PubMed ID: 23682779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategy and planning for chemopreventive drug development: clinical development plans II.
    Kelloff GJ; Crowell JA; Hawk ET; Steele VE; Lubet RA; Boone CW; Covey JM; Doody LA; Omenn GS; Greenwald P; Hong WK; Parkinson DR; Bagheri D; Baxter GT; Blunden M; Doeltz MK; Eisenhauer KM; Johnson K; Knapp GG; Longfellow DG; Malone WF; Nayfield SG; Seifried HE; Swall LM; Sigman CC
    J Cell Biochem Suppl; 1996; 26():54-71. PubMed ID: 9154168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of dietary phytochemical chemopreventive agents: biomarkers and choice of dose for early clinical trials.
    Scott EN; Gescher AJ; Steward WP; Brown K
    Cancer Prev Res (Phila); 2009 Jun; 2(6):525-30. PubMed ID: 19470784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoprevention of skin melanoma: facts and myths.
    Uzarska M; Czajkowski R; Schwartz RA; Bajek A; Zegarska B; Drewa T
    Melanoma Res; 2013 Dec; 23(6):426-33. PubMed ID: 24077511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer chemoprevention - selected molecular mechanisms.
    Walczak K; Marciniak S; Rajtar G
    Postepy Hig Med Dosw (Online); 2017 Mar; 71(0):149-161. PubMed ID: 28258675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer chemoprevention by dietary constituents: a tale of failure and promise.
    Gescher AJ; Sharma RA; Steward WP
    Lancet Oncol; 2001 Jun; 2(6):371-9. PubMed ID: 11905754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer risk factors for selecting cohorts for large-scale chemoprevention trials.
    Greenwald P
    J Cell Biochem Suppl; 1996; 25():29-36. PubMed ID: 9027595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoprevention of cancer.
    Szarka CE; Grana G; Engstrom PF
    Curr Probl Cancer; 1994; 18(1):6-79. PubMed ID: 8005001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemopreventive potential of epigallocatechin gallate and genistein: evidence from epidemiological and laboratory studies.
    Park OJ; Surh YJ
    Toxicol Lett; 2004 Apr; 150(1):43-56. PubMed ID: 15068824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer chemoprevention. Part 2: Hormones, nonclassic antioxidant natural agents, NSAIDs, and other agents.
    Singh DK; Lippman SM
    Oncology (Williston Park); 1998 Dec; 12(12):1787-800; discussion 1802, 1805. PubMed ID: 9874850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chemoprevention of cancer. Prevention of cancer in groups with increased risk].
    Sanner T; Dybing E
    Tidsskr Nor Laegeforen; 1996 Aug; 116(19):2329-33. PubMed ID: 8804210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blocking and suppressing mechanisms of chemoprevention by dietary constituents.
    Manson MM; Gescher A; Hudson EA; Plummer SM; Squires MS; Prigent SA
    Toxicol Lett; 2000 Mar; 112-113():499-505. PubMed ID: 10720772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of cancer chemoprevention by soy isoflavone genistein.
    Sarkar FH; Li Y
    Cancer Metastasis Rev; 2002; 21(3-4):265-80. PubMed ID: 12549765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New perspectives of curcumin in cancer prevention.
    Park W; Amin AR; Chen ZG; Shin DM
    Cancer Prev Res (Phila); 2013 May; 6(5):387-400. PubMed ID: 23466484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.